U.S. Banks Stock News

In recent weeks, IREN’s repositioning toward AI infrastructure has gained momentum, anchored by a five‑year, roughly US$9.70 billion AI cloud services contract with Microsoft and backed by large convertible note and equity financings to fund GPU‑rich data centers. These developments mark a shift in IREN’s business mix from primarily Bitcoin mining toward long‑duration, enterprise AI cloud revenue, tying its fortunes more closely to hyperscaler demand than to crypto cycles. We’ll now examine...

Bank OZK (OZK) is back in the spotlight after arranging $96.7 million in non recourse financing for three stabilized industrial properties in Rockford, Illinois, including a new 155,000 square foot facility. See our latest analysis for Bank OZK. For shareholders, the picture is mixed but constructive. The latest $47.19 share price sits above its start-of-year level and is underpinned by a solid five-year total shareholder return of 79.21 percent. This suggests momentum is cooling in the short...

USA Compression Partners (USAC) has quietly pulled back over the past month even as its underlying business keeps growing. That disconnect between sliding unit price and improving fundamentals is exactly what income focused investors should notice. See our latest analysis for USA Compression Partners. At around $23.11 today, USA Compression Partners’ recent pullback follows a modestly negative 3 month share price return but sits against a much stronger backdrop, with a 1 year total...

In recent weeks, Moderna secured up to US$54.3 million in CEPI funding to advance late-stage development of its bird flu vaccine candidate mRNA-1018 and received a positive opinion from the European Medicines Agency recommending authorization of its next-generation COVID-19 vaccine, mNEXSPIKE. Together, this external funding support and EU regulatory progress underline how Moderna is seeking to extend its mRNA franchise beyond seasonal COVID demand and into broader pandemic...

In early December 2025, Procore Technologies announced that long-time director Brian Feinstein resigned from its board and was immediately replaced by software industry veteran Ronald Hovsepian, who also joined the Compensation and Nominating committees. Alongside this board refresh, Procore reported year-over-year revenue growth of 14.5% in the third quarter and rising performance obligations, reinforcing confidence in its leadership and long-term demand for its construction management...

Veralto (VLTO) just gave income investors something to consider, with the board approving an 18% increase to its quarterly dividend to $0.13 per share, indicating confidence in the company’s earnings power. See our latest analysis for Veralto. The dividend hike lands as Veralto’s 1 month share price return of 4.23 percent suggests cautious optimism is creeping back in, even though the 1 year total shareholder return is still slightly negative, hinting at early but not runaway momentum. If...

In December 2025, Allegiant Travel reported its November operating results, showing Scheduled Service passengers rising to 1,343,190 and revenue passenger miles reaching 1.22 billion, with load factor holding near prior-year levels. What stands out is that Allegiant added more than 800 extra departures year over year while keeping aircraft just as full, suggesting capacity growth was absorbed without sacrificing utilization. Next, we’ll examine how this higher passenger volume and increased...

In a robust market environment where the Dow Jones and S&P 500 have recently set new records, investors are keenly observing opportunities that may be overlooked amid widespread gains. Identifying undervalued stocks can be particularly rewarding in such conditions, as they offer potential value not yet recognized by the broader market.

As the U.S. stock market continues to hit new highs, with the S&P 500 setting an all-time record and major indices posting consistent gains, investors are keenly observing growth opportunities. In this thriving environment, companies with high insider ownership often attract attention due to the potential alignment of interests between management and shareholders, making them compelling considerations for those seeking robust growth prospects.

As the U.S. stock market continues to set new records, with the Dow Jones and S&P 500 reaching all-time highs, investors are exploring diverse opportunities beyond blue-chip stocks. Penny stocks, a term that has evolved from its speculative roots, still present intriguing possibilities for those willing to explore smaller or newer companies offering potential growth. In this article, we will discuss three penny stocks that stand out due to their financial resilience and potential for...

Amidst a backdrop of record-setting highs for major indices like the S&P 500 and Dow Jones Industrial Average, the U.S. stock market continues to capture investor attention with its robust performance. In this thriving environment, discovering stocks that are not yet in the spotlight but show potential can be rewarding for investors seeking growth opportunities beyond blue-chip names.

As the U.S. stock market continues to set new records with the Dow Jones and S&P 500 reaching all-time highs, investors are increasingly focused on finding stable income sources amidst rising indices. In this environment, dividend stocks like Banner and others can offer reliable returns through consistent payouts, making them an attractive option for those seeking steady income in a thriving market.

In December 2025, Commercial Metals Company amended its credit agreement to lift its revolving credit facility from US$600.0 million to US$1.00 billion, extend its maturity to December 2030, and add flexibility for up to US$250.0 million in additional revolver or term loan capacity, while also benefiting from a very large preliminary anti-dumping margin on Algerian rebar imports into the U.S. Coupled with an US$18.4 million power infrastructure upgrade at its West Virginia plant, the...

Earlier this month, Invesco and Galaxy Asset Management launched the Invesco Galaxy Solana ETP (QSOL), a regulated product offering direct exposure to Solana’s spot price via the Lukka Prime Solana Reference Rate, expanding Invesco’s digital asset line-up alongside its Bitcoin and Ethereum ETPs. The move underscores Invesco’s push to broaden access to emerging blockchain infrastructure and positions its growing digital assets suite as a complement to its more traditional ETF offerings. Now,...

H2O America recently appointed Nicholas Whitley as vice president of business development, effective December 22, 2025, tasking him with leading the identification, evaluation, and execution of new water and wastewater growth opportunities across the company’s footprint. This hire brings more than 20 years of corporate development and infrastructure investing experience into H2O America’s leadership team, underscoring a clear emphasis on expansion through complex, multi-jurisdictional...

Inspire Medical Systems (INSP) is back in the spotlight after a wave of securities class actions accused the company of downplaying serious launch problems with its Inspire V sleep apnea device. See our latest analysis for Inspire Medical Systems. The lawsuits froze sentiment just as the business was showing double digit revenue and profit growth. The stock reflects that shift in risk perception, with a 30 day share price return of minus 18.45 percent, a year to date share price return of...

In recent days, Caterpillar has drawn heightened attention as analysts highlighted its expanding role in power generation for AI data centers, reaffirmed positive ratings, and the company confirmed it will maintain its quarterly dividend of US$1.51 per share while advancing new technology features across its equipment lineup. At the same time, Caterpillar’s push into autonomous mining, enhanced service commitments, and data center energy-optimization partnerships underscores its shift toward...

In recent months, SELLAS Life Sciences Group has reported encouraging clinical data in leukemia, including a 46% response rate and favorable FDA designations for its oncology programs. These updates have drawn heightened attention to SELLAS as an emerging player in cancer therapeutics, despite ongoing losses and substantial research spending. Against this backdrop, we’ll explore how the encouraging leukemia trial results shape SELLAS Life Sciences Group’s investment narrative for long-term...

Oshkosh (OSK) has quietly built a strong track record, with the stock up about 40% over the past year as steady revenue and earnings growth reshape how investors value this industrial name. See our latest analysis for Oshkosh. That momentum has not come out of nowhere, with the recent pullback in the 1 day share price move sitting against a near 40% year to date share price return and a roughly 40% one year total shareholder return. This suggests investors are steadily repricing Oshkosh for...

Jabil (JBL) has been quietly rewarding patient shareholders, with the stock up about 19% over the past month and nearly 12% in the past 3 months, well ahead of broader benchmarks. See our latest analysis for Jabil. Zooming out, that recent strength builds on a powerful backdrop, with a roughly 64 percent year to date share price return and a five year total shareholder return above 460 percent suggesting momentum is still very much intact. If Jabil has you rethinking what consistent execution...

ServisFirst Bancshares (SFBS) has approved another increase to its quarterly cash dividend, raising the payout from $0.335 to $0.38 per share. This move reinforces the stock’s appeal for income-focused investors. See our latest analysis for ServisFirst Bancshares. Even with the higher payout, ServisFirst’s latest share price of $73.80 reflects a weaker 90 day share price return and negative year to date performance, though its five year total shareholder return still points to solid long term...

Recent performance and why Elevance Health is on investors’ radar Elevance Health (ELV) has been quietly grinding higher, with shares up about 4% over the month and roughly 8% in the past 3 months, even as the stock remains down year to date. See our latest analysis for Elevance Health. The latest move to around $343.30 continues a steady recovery, with the 3 month share price return of 8.4% contrasting with a weaker year to date share price return and a muted 1 year total shareholder return...

Four Corners Property Trust (FCPT) has quietly drifted lower this year, even as its rental income and earnings continue to climb at a steady pace. This creates an interesting setup for income-focused investors. See our latest analysis for Four Corners Property Trust. At around $23.42 per share, Four Corners’ 1 year to date share price return of negative 12.64 percent contrasts with a modestly positive 3 year total shareholder return of 5.96 percent. This suggests short term momentum is fading...

Otis Worldwide has completed its landmark installation for Montréal’s Réseau Express Métropolitain light metro, supplying 22 escalators and 57 custom elevators with energy‑saving ReGen drives and real‑time monitoring tied into the network’s centralized control system. The project not only enhances accessibility and sustainability for up to 150,000 daily passengers but also adds a 5‑year service contract that deepens Otis’s recurring maintenance and monitoring role in one of Québec’s largest...